In 1981, two systems were installed, one at Liverpool Royal Infirmary, the other at St James’s Hospital, Leeds. The next year, three more UK installations followed, and then further expansion was seen with the first installation in the US at the Henry Ford Hospital, Detroit. The year after, saw even more sites added to the portfolio in the UK and the US, including five systems at the prestigious Mayo Clinic.
By the late 1980’s, the majority of UK Renal Units used the system. As technology developed, the system did too. In 1988, it was re-developed for the popular IBM PCs, and ‘Proton’ was born, one of the earliest electronic patient records in the world. A product still in use today, albeit with a few enhancements.
The largest customer for Proton was National Medical Care (NMC) in Boston. At the time, they owned and operated over 500 dialysis centres throughout North America. Due to the scale of the operation, Conrad visited them many times in the 1990’s, sometimes up to 3 weeks at a time, helping them to develop their own standard renal application. Over time, they opened further centres that required additional licences, culminating with Proton in over 2,000 centres.
Between 1996-2000, the system was further redeveloped for Windows, and the first version of Clinical Vision was established. By this point CCL had clients in Europe, North America, Saudi Arabia, Australia and New Zealand. Conrad travelled the world to support individual client installations.
I still remember in the early days, the many nights spent in a small dark machine room with no windows at Charing Cross Hospital, to produce the machine code for the first prototype system. It made studying at college the next day a little more challenging!
In the UK, Proton data was used on a broader scale to compare the performance of different units, looking at metrics such as death rates, transplantation and other health markers. Today, this is known as the UK Renal Registry (UKRR), which Clinical Vision integrates with directly. The data collected is used to support research into improved care and better patient outcomes.
In 2017, CCL was acquired by Constellation Software, Inc., but Conrad’s contribution to kidney care software didn’t end there. Conrad’s expertise has continued to shape CKG’s market-leading solutions to this day.